AlphaYouSP
Insider selling
Steve Pakola sold $169K of REGENXBIO Inc. (RGNX) stock
Steve Pakola, Chief Medical Officer of REGENXBIO Inc. (RGNX), sold 15,309 shares of RGNX stock worth $169K, per an SEC Form 4 filed May 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 11, 2026, 2 days before it was made public.
RGNX has moved -21.8% since the trade date, from $10.08 to $7.88 (Sep 21, 2026 close).
- Traded
- May 11, 2026
- Disclosed
- May 13, 2026
- Filing delay
- 2 days
- Price since
- -21.8%
- Role
- Chief Medical Officer
- Source
- SEC Form 4
More RGNX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.